Cardiology : (Record no. 2996)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 07348nam a22004453i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC5432889 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240724113236.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2016 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781498779821 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781498779814 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC5432889 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL5432889 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1042325375 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC683 .L345 2016 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.12075 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Laflamme, David. |
| 245 10 - TITLE STATEMENT | |
| Title | Cardiology : |
| Remainder of title | A Practical Handbook. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Milton : |
| Name of producer, publisher, distributor, manufacturer | Taylor & Francis Group, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2016. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2016. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (396 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Cover -- Half Title -- Title -- Copyright -- Foreword -- Table of Contents -- Dedication -- Preface -- Scientific revision -- Legal statement -- 01 CARDIAC DIAGNOSTIC ASSESSMENT -- 1.1/ Cardiac physical examination -- 1.2/ Electrocardiogram (ECG) -- 1.3/ Stress test -- 1.4/ Transthoracic echocardiography (TTE) -- 1.5/ Transesophageal echocardiography (TEE) -- 1.6/ Stress echocardiography -- 1.7/ Chest x-ray (CXR) -- 1.8/ Coronary angiography -- 1.9/ Hemodynamic assessment -- 1.10/ Cardiac nuclear medicine -- 1.11/ Cardiac magnetic resonance imaging (cardiac MRI) -- 1.12/ Cardiac CT scan -- 1.13/ Cardiopulmonary exercise testing -- 1.14/ Exposure to radiation during cardiac examinations -- 02 CORONARY ARTERY DISEASE (CAD) & -- MYOCARDIAL INFARCTION -- 2.1/ Stable angina -- 2.2/ Biomarkers -- 2.3/ Myocardial infarction: Definition -- 2.4/ Unstable angina & -- NSTEMI -- 2.5/ STEMI -- 2.6/ Acute coronary syndrome: Adjuvant treatments -- 2.7/ Complications of myocardial infarction -- 2.8/ Revascularization - PCI -- 2.9/ Revascularization - Coronary artery bypass graft -- 2.10/ Prinzmetal angina (vasospastic angina) -- 2.11/ Cardiac syndrome X -- 03 HEART FAILURE -- 3.1/ Heart failure: assessment -- 3.2/ Systolic heart failure: management -- 3.3/ Diastolic heart failure (preserved LVEF) -- 3.4/ Decompensated heart failure -- 3.5/ Heart transplantation -- 3.6/ Long-term ventricular assist device -- 3.7/ Right heart failure -- 3.8/ Palliative care -- 04 VALVULAR HEART DISEASE -- 4.1/ Aortic stenosis -- 4.2/ Chronic aortic regurgitation -- 4.3/ Acute aortic regurgitation -- 4.4/ Mitral stenosis -- 4.5/ Chronic mitral regurgitation -- 4.6/ Acute mitral regurgitation -- 4.7/ Tricuspid stenosis -- 4.8/ Tricuspid regurgitation -- 4.9/ Pulmonary stenosis -- 4.10/ Pulmonary regurgitation -- 4.11/ Multivalvular heart disease -- 4.12/ Valvular prostheses. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.13/ Infective endocarditis -- 4.14/ Cardiovascular implantable electronic device infection -- 4.15/ Rheumatic fever -- 05 DISEASES OF THE PERICARDIUM & -- MYOCARDIUM -- 5.1/ Diseases of the pericardium: etiologies -- 5.2/ Acute pericarditis -- 5.3/ Incessant and recurrent pericarditis -- 5.4/ Cardiac tamponade -- 5.5/ Constrictive pericarditis -- 5.6/ Congenital anomalies of the pericardium -- 5.7/ Cardiomyopathies - Classification -- 5.8/ Hypertrophic cardiomyopathy -- 5.9/ Dilated cardiomyopathy -- 5.10/ Restrictive cardiomyopathy -- 5.11/ Cardiac amyloidosis -- 5.12/ Arrhythmogenic right ventricular dysplasia (ARVD) -- 5.13/ Isolated left ventricular noncompaction -- 5.14/ Takotsubo (stress) cardiomyopathy -- 5.15/ Myocarditis -- 5.16/ Indications for endomyocardial biopsy -- 5.17/ Cardiac tumors -- 5.18/ Cardiac complications of cancer -- 06 ARRHYTHMIAS -- 6.1/ Physiology -- 6.2/ Bradyarrhythmias -- 6.3/ Supraventricular tachyarrhythmias -- 6.4/ Atrial fibrillation -- 6.5/ Ventricular tachyarrhythmias -- 6.6/ Channelopathies -- 6.7/ Syncope -- 6.8/ Antiarrhythmic drugs (AAD) -- 6.9/ Amiodarone -- 6.10/ Permanent pacemaker (PPM) -- 6.11/ Cardiac resynchronization therapy (CRT) -- 6.12/ Implantable cardioverter-defibrillator (ICD) -- 07 ADULT CONGENITAL HEART DISEASE & -- HEART DISEASE IN PREGNANT WOMEN -- 7.1/ Segmental assessment & -- fetal circulation -- 7.2/ Atrial septal defect (ASD) -- 7.3/ Patent foramen ovale (PFO) -- 7.4/ Ventricular septal defect (VSD) -- 7.5/ Atrioventricular canal defect -- 7.6/ Patent ductus arteriosus -- 7.7/ Left ventricular outflow tract obstruction -- 7.8/ Coarctation of the aorta (CoA) -- 7.9/ Right ventricular outflow tract obstruction -- 7.10/ Tetralogy of Fallot (TOF) -- 7.11/ Transposition of the great arteries (D-TGV) -- 7.12/ Congenitally corrected Transposition of the great arteries (L-TGV). |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 7.13/ Ebstein's anomaly -- 7.14/ Marfan syndrome -- 7.15/ Fontan procedure -- 7.16/ Eisenmenger syndrome -- 7.17/ Cyanotic heart disease -- 7.18/ Anomalous pulmonary venous connection -- 7.19/ Congenital coronary artery anomalies -- 7.20/ Vascular annulus -- 7.21/ Cor triatriatum -- 7.22/ Heart disease in pregnant women -- 08 PERIPHERAL VASCULAR DISEASE -- 8.1/ Aneurysm of the thoracic aorta -- 8.2/ Acute aortic syndrome -- 8.3/ Abdominal aortic aneurysm (AAA) -- 8.4/ Other aortic diseases -- 8.5/ Peripheral artery disease (PAD) -- 8.6/ Atherosclerotic renovascular disease -- 8.7/ Cerebrovascular disease -- 8.8/ Pulmonary embolism -- 8.9/ Heparin-induced thrombocytopenia (HIT) -- 8.10/ Pulmonary hypertension -- 09 MISCELLANEOUS -- 9.1/ Preoperative assessment (non cardiac surgery) -- 9.2/ Primary & -- secondary prevention of cardiovascular disease -- 9.3/ Smoking cessation -- 9.4/ Dyslipidemia -- 9.5/ Hypertension -- 9.6/ Diabetes -- 9.7/ Physical activity -- 9.8/ Weight & -- Diet -- 9.9/ Obstructive sleep apnea syndrome -- 9.10/ Driving & -- Air travel -- 9.11/ Cardiovascular complications of systemic diseases -- 9.12/ Cardiovascular complications of trauma -- 9.13/ Poisoning -- 9.14/ Swan-Ganz catheter placement -- 9.15/ Cardiopulmonary resuscitation -- ABBREVIATIONS -- ★ CLINICAL TRIALS CITED -- INDEX. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | There has been an exponential increase in the amount of information available on the pathophysiology and management of heart diseases. Meanwhile, understanding of the underlying pathology and physiology has deepened and broadened with new methodologies to monitor cardiac structure and function. These developments have led to an overwhelming amount of information available to students, trainees, and physicians. What is in short supply is a comprehensive yet concise and clear description of the important cardiac conditions and disorders, an approach to their management, and an easily consulted and well-indexed summary to be used at the bedside or in the clinic. This book addresses that need. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart-Diseases-Diagnosis. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Laflamme, David |
| Title | Cardiology |
| Place, publisher, and date of publication | Milton : Taylor & Francis Group,c2016 |
| International Standard Book Number | 9781498779814 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5432889">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5432889</a> |
| Public note | Click to View |
No items available.